The DOJ backs Medicare price negotiations amidst a Novartis lawsuit, while President Trump vows to lower U.S. drug costs.

The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...

President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive ...

The U.S. Department of Justice has filed an appeals court brief supporting the right of Medicare officials to negotiate ...

The Trump administration is moving forward with the defense of a Biden-era plan that allows Medicare to negotiate drug prices ...

U.S. President Donald Trump will meet on Thursday with chief executives from major drugmakers, a White House official ...

Medicare is a government program that provides health insurance coverage for senior citizens age 65 years and older, the disabled of any age, and to anyone suffering from end-stage renal disease.

A new study from the USC Schaeffer Center shows that out-of-pocket costs for brand-name medications have increased sharply ...

Worried about skyrocketing prescription drug costs? Medicare's new spending cap is bringing welcome relief to seniors, with ...

Expected out of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D beneficiaries as drug plans increasingly tie patient costs to list prices, ...

Once you turn 65, you’re eligible for health coverage under Medicare. But that doesn’t mean you should stick with original ...

Expected out-of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D ...